Schizophrenia offender drug study pulled before it started
NCT ID NCT05939765
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was designed to observe how doctors choose medications for people with schizophrenia who have committed violent crimes. It planned to track changes in symptoms and aggressive behavior over time. However, the study was withdrawn before enrolling any participants, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Started
-
Dec 2025
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The Center for Inpatient Forensic Therapy (ZSFT: Zentrum für Stationäre ForensischeTherapie \[German\]), which is part of the Clinic for Forensic Psychiatry of the Psychiatric Hospital of the University of Zurich is Switzerland's largest forensic psychiatric clinic specializing in the treatment of imprisoned patients suffering from psychiatric disorders.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria * Participants are competent to give informed consent. * Participants are between 18 and 65 years of age. * Diagnosis of schizophrenia DSM-5 * Violent crime in the course of a psychotic episode. * German language proficiency Exclusion criteria * Low intelligence * Current neurological disorder * Substance induced psychotic disorder
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Schizophrenia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Psychiatrische Universitätsklinik Zürich
Zurich, Canton of Zurich, 8032, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your voice may reveal if You're taking your psychiatric medication
- Scientists probe brain's reward system in mental illness
- New schizophrenia drug targets brain glutamate, not dopamine
- New drug candidate takes aim at schizophrenia symptoms
- New schizophrenia drug goes Head-to-Head with standard antipsychotics in Long-Term trial
- Five-Year safety check for experimental schizophrenia drug